ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:US20150315144A1
公开(公告)日:2015-11-05
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US10369140B2
公开(公告)日:2019-08-06
The present invention provides compounds of Formula (I):
or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.